Literature DB >> 20425377

Epstein-Barr virus-related lymphoproliferative disorders.

Nina D Wagner-Johnston1, Richard F Ambinder.   

Abstract

Esptein-Barr virus (EBV) is a ubiquitous gammaherpesvirus that persists in carriers as a lifelong, mostly asymptomatic infection. EBV is associated with a variety of lymphomas and lymphoproliferative disorders. In this review we provide an update of the relevant literature on EBV-associated lymphoproliferative disorders, with particular emphasis on epidemiology, pathogenesis, and novel treatment approaches.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 20425377     DOI： 10.1007/s11899-007-0034-y

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN： 1558-8211            Impact factor:   3.952


  33 in total

1.  Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma.

Authors:  María Dolores Fellner; Karina Durand; Rita Mariel Correa; Liliana Redini; Claudio Yampolsky; Antonio Colobraro; Gustavo Sevlever; Angélica R Teyssié; Jorge Benetucci; María Alejandra Picconi
Journal:  Int J Infect Dis       Date:  2006-08-23       Impact factor: 3.623

2.  CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients.

Authors:  M Green; M G Michaels; B Z Katz; M Burroughs; D Gerber; B L Shneider; K Newell; D Rowe; J Reyes
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

3.  Functional reversion of antigen-specific CD8+ T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope.

Authors:  Corey Smith; Leanne Cooper; Melinda Burgess; Michael Rist; Natasha Webb; Eleanore Lambley; Judy Tellam; Paula Marlton; John F Seymour; Maher Gandhi; Rajiv Khanna
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

4.  Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

Authors:  Ola Landgren; Eric A Engels; Ruth M Pfeiffer; Gloria Gridley; Lene Mellemkjaer; Jørgen H Olsen; Kimberly F Kerstann; William Wheeler; Kari Hemminki; Martha S Linet; Lynn R Goldin
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

5.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 6.  Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.

Authors:  Andreas Bräuninger; Roland Schmitz; Dörte Bechtel; Christoph Renné; Martin-Leo Hansmann; Ralf Küppers
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

7.  Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas.

Authors:  Hyun-Il Cho; Young Seon Hong; Myung Ah Lee; Eun-Kyung Kim; Sung-Hee Yoon; Chun-Choo Kim; Tai-Gyu Kim
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

8.  Trends in cancer risk among people with AIDS in the United States 1980-2002.

Authors:  Eric A Engels; Ruth M Pfeiffer; James J Goedert; Phillip Virgo; Timothy S McNeel; Steven M Scoppa; Robert J Biggar
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

9.  Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.

Authors:  Ayako Demachi-Okamura; Yoshinori Ito; Yoshiki Akatsuka; Kunio Tsujimura; Yasuo Morishima; Toshitada Takahashi; Kiyotaka Kuzushima
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

10.  A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.

Authors:  R Newton; L Carpenter; D Casabonne; V Beral; A Babiker; J Darbyshire; I Weller; R Weiss; A Kwan; D Bourboulia; F Munoz; D Lagos; C Boshoff
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640
View more
  1 in total

1.  Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency In Vivo.

Authors:  Arundhati Gupta; Shana M Owens; Darby G Oldenburg; Douglas W White; J Craig Forrest
Journal:  J Virol       Date:  2022-06-01       Impact factor: 6.549
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.